{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:10:16Z","timestamp":1788379816888,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.clinthera.2017.05.355","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T17:16:11Z","timestamp":1500916571000},"page":"1371-1379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects"],"prefix":"10.1016","volume":"39","author":[{"given":"Mi Jin","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Hwan","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Gyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geun Hyeog","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Seok","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Yeon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon-Gon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2017.05.355_bib1","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/0002-8703(89)90834-X","article-title":"The pharmacokinetic profile of amlodipine","volume":"118","author":"Abernethy","year":"1989","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2017.05.355_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00003088-199222010-00003","article-title":"Clinical pharmacokinetics of amlodipine","volume":"22","author":"Meredith","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2017.05.355_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2165\/00003495-199550030-00009","article-title":"Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease","volume":"50","author":"Haria","year":"1995","journal-title":"Drugs"},{"issue":"Suppl 7","key":"10.1016\/j.clinthera.2017.05.355_bib4","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/00005344-198812007-00012","article-title":"The metabolism and pharmacokinetics of amlodipine in humans and animals","volume":"12","author":"Stopher","year":"1988","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.clinthera.2017.05.355_bib5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0149-2918(03)80066-8","article-title":"Olmesartan medoxomil: an angiotensin II-receptor blocker","volume":"25","author":"Brousil","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2017.05.355_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1753944711432902","article-title":"Olmesartan\/amlodipine: blood pressure lowering and beyond in special populations","volume":"6","author":"Erdine","year":"2012","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.clinthera.2017.05.355_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.clinthera.2008.04.002","article-title":"The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double blind, placebo-controlled, 8-week factorial efficacy and safety study","volume":"30","author":"Chrysant","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2017.05.355_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1751-7176.2009.00159.x","article-title":"Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension","volume":"11","author":"Chrysant","year":"2009","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.clinthera.2017.05.355_bib9","unstructured":"Lodien tab. http:\/\/www.hanlim.com\/product\/product_search.php?cmd=view&pd_no=311&cd_code=&skey=all&sword=lodien&page=1. Accessed July 5, 2016."},{"key":"10.1016\/j.clinthera.2017.05.355_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00005344-200202000-00007","article-title":"Paradoxical release of nitric oxide by an L-type calcium channel antagonist, the R+ enantiomer of amlodipine","volume":"39","author":"Zhang","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.clinthera.2017.05.355_bib11","first-page":"187","article-title":"Chiral molecules in hypertension: focus on S-amlodipine","volume":"52","author":"Adik-Pathak","year":"2004","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.clinthera.2017.05.355_bib12","unstructured":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/. Accessed July 5, 2016."},{"key":"10.1016\/j.clinthera.2017.05.355_bib13","unstructured":"Ministry of Food and Drug Safety (MFDS): Korean Good Clinical Practice (KGCP) guidelines [in Korean]. http:\/\/drug.mfds.go.kr\/html\/menuLinkBody.jsp. Accessed July 5, 2016."},{"key":"10.1016\/j.clinthera.2017.05.355_bib14","series-title":"Design and Analysis of Bioavailability and Bioequivalence Studies","first-page":"1","author":"Chow","year":"2000"},{"key":"10.1016\/j.clinthera.2017.05.355_bib15","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.clinthera.2006.11.008","article-title":"Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: a randomized, open-label, two-period, comparative, crossover study","volume":"28","author":"Park","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2017.05.355_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.12793\/jkscpt.2012.20.2.145","article-title":"Bioequivalence and dose proportionality of olmesartan medoxomil formulations","volume":"20","author":"Cho","year":"2012","journal-title":"J Kor Soc Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2017.05.355_bib17","unstructured":"US FDA. Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products \u2013 general considerations. 2003."},{"key":"10.1016\/j.clinthera.2017.05.355_bib18","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.clinthera.2012.08.003","volume":"34","author":"Oh","year":"2012","journal-title":"Clin Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817306641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817306641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:57:11Z","timestamp":1535590631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291817306641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0149291817306641"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.05.355","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.05.355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}